-
Science Saturday: Researchers investigate precision nutrition to improve health, prevent diseases
Share this:
Could prescribing specific nutrients, grains, fruits and vegetables tailored to a person's DNA and other biological characteristics help improve their health?
Precision nutrition took center stage at Mayo Clinic's Individualizing Medicine Conference Nov. 2–3, 2022, in Rochester, Minnesota, where some of the world’s top experts shared their knowledge of the potential benefits of tailoring nutrients and dietary guidance to a person's genes, metabolism, microbiome and other distinguishing characteristics. The ultimate goal of the holistic approach is to promote health and help prevent diet-related diseases, including heart disease, diabetes and some cancers.
Research shows nearly 11 million deaths worldwide are linked to diet-related factors annually, along with the contributing impacts of genetics, age, gender, weight, and deficiencies in sleep and exercise.
Just as people respond differently to certain medications, known as pharmacogenomics, a person's genes and lifestyle also can alter their responses to the foods they eat, including how their body metabolizes, absorbs and distributes nutrients.
Precision nutrition is part of a new era in individualized medicine, driven by advances in multi-omic approaches — with particular attention on metabolomics, which is the study of substances created when the body breaks down food, drugs or its own tissue.
Read the rest of the article on the Individualized Medicine blog.
____________________________________________
Other Mayo Clinic medical research websites:
- Research at Mayo Clinic
- Discovery’s Edge
- Advancing the Science
- Mayo Clinic Laboratories
- Forefront
- Center for Regenerative Biotherapeutics
- Center for the Science of Health Care Delivery
- Mayo Clinic Cancer Center
Share this:
Related articles
Mayo Clinic seeks to harness the power of cells, tissue and genes by delivering first-of-their kind therapeutics for patients in early-stage clinical trials. Mayo Clinic's Center ...
ROCHESTER, Minn. — Patients who received the anticoagulant drug warfarin after bioprosthetic aortic valve replacement had lower incidence of mortality and a decreased risk of ...
When Joanina Gicobi began her Ph.D. degree five years ago at Mayo Clinic Graduate School of Biomedical Sciences, she was interested in thinking creatively about ways ...